Omnicare (OCR) Buys Advanced Care Scripts
More News related to OCR
- Omnicare to Present at the Thomas Weisel Partners Healthcare Conference
- Buckingham Research Downgrades to Omnicare (OCR) Neutral
- JANA Partners 13F Shows New Stakes in Genentech (DNA), Sears (SHLD), Washington Mutual (WM); Adds to Positions in AK Steel (AKS), Focus Media (FMCN), Transocean (RIG); Sells Out of Apple (AAPL), Lehma
- Omnicare Declares Quarterly Cash Dividend
- Jefferies Upgrades Omnicare (OCR) to Buy
More News related to Mergers and Acquisitions
- LTX (LTXX) and Credence (CMOS) Complete Merger to Form LTX-Credence; Will Trade Under "LTXC"
- Gilat Satellite Networks (GILT) Terminates Merger Agreement with Consortium of Buyers; Will Receive $47.3M Termination Fee
- Gilat Satellite (GILT) Terminates Acquisition Agreement with Private Equity Consortium
- International Rectifier (IRF) Rejects Offer From Vishay Intertechnology (VSH)
- The PMI Group (PMI) Agrees to Sell Asia Operations for $56M
Omnicare, Inc. (NYSE: OCR) today announced the acquisition of specialty pharmaceutical services provider, Advanced Care Scripts, Inc., for an undisclosed amount. The transaction is expected to be modestly accretive to Omnicare's earnings in 2008, with accretion expected to increase in 2009 and beyond.
Advanced Care Scripts provides both specialty pharmacy and product support services for the pharmaceutical and biotechnology industries. Its specialty pharmacy operations dispense high-cost oral and injectable medications directly to patients and provide a range of related clinical and administrative services. Its product support services division provides pharmaceutical and biotechnology companies with a range of services, including reimbursement support, compliance monitoring, patient assistance programs and data management. Advanced Care Scripts' business is focused currently on disease states within neurology and oncology.
Based on the quarter ended March 31, 2008, Advanced Care Scripts' revenues are running at an annualized rate of approximately $212 million.
Omnicare, Inc., a geriatric pharmaceutical services company, provides pharmaceuticals and related ancillary pharmacy services.
Related Categories
Mergers and AcquisitionsStocks Mentioned
-0.36Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
